Skip to content
Online Event
  • April 4, 2022 from 12:00pm to 1:00pm

Special note: This seminar will be hosted on Zoom. Please register to receive the link and password two hours before the seminar. Please note that space is limited.

Speaker: Dr. Brenda Coleman, Assistant Professor, Dalla Lana School of Public Health, University of Toronto; Infectious Disease Epidemiologist and Clinical Scientist, Mount Sinai Hospital

Title: TBC

Speaker Bio:

Dr. Coleman worked in public health, as an epidemiologist, for 10 years before graduating with her PhD in public health. Since then she has been an independent researcher and manager of the Infectious Disease Epidemiology Research Unit at Mount Sinai Hospital. She has also been an Assistant Professor in the Dalla Lana School of Public Health since 2010. Dr. Coleman’s areas of interest and research include vaccines and respiratory diseases including influenza and COVID-19 as well as antimicrobial resistance, both antiviral and antibiotic. Her goal is to reduce the transmission of infectious diseases and thereby reduce of the burden of illness.

Dr. Coleman is currently conducting two large prospective cohort studies about COVID-19; one with hospital workers and the other with education workers. The objective of these studies is to determine what factors put our essential workers at risk for infection; they also investigate vaccine effectiveness, stress of working during a pandemic, and antibody levels over time. These findings will be used to prevent transmission and illnesses – of COVID and other respiratory diseases.

About the Centre for Vaccine Preventable Diseases, DLSPH:

With leadership housed at the University of Toronto’s Dalla Lana School of Public Health, we are developing an interdisciplinary group of academic researchers, educators and public health advocates. Our vision is to catalyze cutting-edge research and education that maximizes the health benefits of immunization for everyone.

We aim to contribute locally and globally to healthy communities through excellence in interdisciplinary vaccine-preventable disease and immunization research and education.

Questions? Email us at